NCT07766187: Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 12 planned
- Started
- Nov 2026
- Primary completion
- Aug 2032
- Arms
- Participants with advanced iCCA
- Results
- None posted
- 14 Aug 2026: Trial registered